Class II — Potential Health Hazard

Potential health hazard — use of or exposure to this product may cause temporary or medically reversible adverse health consequences.

Ultra2 Resolution Variants System for Abnormal Hemoglobin Quantitation Recalled by Primus Corporation Due to The product did not receive pre-market approval or...

Date: October 9, 2020
Company: Primus Corporation
Status: Terminated
Source: FDA (Device)

What You Should Do

Stop using this product immediately. Do not consume, use, or distribute it.

Return the product to the place of purchase for a full refund. If you have questions, contact Primus Corporation directly.

Affected Products

Ultra2 Resolution Variants System for Abnormal Hemoglobin Quantitation

Quantity: 97 devices (USA only)

Why Was This Recalled?

The product did not receive pre-market approval or clearance.

Where Was This Sold?

US - Arizona, California, District of Columbia, Florida, Georgia, Illinois, Louisiana, Massachusetts, Michigan, Missouri, Nebraska, New Jersey, Nevada, New York, Pennsylvania, Rhode Island, Tennessee, Texas, Virginia, Wisconsin OUS - Bahrain, Iran, Malaysia, Saudi Arabia, Taiwan, Turkey, UAE, UK, Vietnam

About Primus Corporation

Primus Corporation has 1 total recall tracked by RecallDetector.

Related Recalls

Data sourced from the FDA (Device). Last updated March 26, 2026. View original report